Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Tellus BioVentures is a biotechnology investment fund founded in 2019, based in the United States. The firm specializes in early-stage innovation and company formation, primarily targeting private biotech ventures at the Seed stage and participating in Series A investments. The organization aims to uncover and accelerate promising life science innovations, enabling talented entrepreneurs to develop therapeutics for patients with unmet medical needs.
Currently, Tellus BioVentures operates with a team of experienced professionals who have backgrounds in commercial development, portfolio management, and operations. The firm often acts as the lead or sole investor in its ventures, providing essential resources and expertise to help portfolio companies achieve critical milestones. Their approach includes launching and funding de novo companies that advance significant innovations lacking necessary resources.
Tellus BioVentures invests primarily in private biotech ventures at the Seed stage, often taking the role of lead or sole investor. The firm also participates in Series A investments, focusing on companies that are developing therapeutics for patients with unmet medical needs. Their investment strategy includes launching and funding de novo companies to support significant innovations in the life sciences sector.
The firm emphasizes providing management support and development expertise to its portfolio companies, which helps them navigate the complexities of early-stage development. Tellus BioVentures is particularly interested in projects that involve extracellular vesicle therapy, monoclonal antibody therapeutics, and next-generation T-cell therapies. Their geographic focus is primarily on the United States, where they can leverage their network and resources to maximize impact.
Tellus BioVentures has a diverse portfolio that includes several innovative companies in the biotechnology sector:
Lonnie Moulder - Managing Member. Lonnie has extensive experience in the biotech sector, having held leadership roles in various companies focused on drug development.
Heidi Kempinski, MBA - Senior Principal & Operating Executive. Heidi brings a wealth of operational expertise and has a strong background in managing biotech ventures.
Lauren Bartlett, MBA - Principal and Vice President of Commercial Development & Corporate Affairs. Lauren specializes in commercial strategy and corporate affairs within the biotech industry.
Meghan Lenihan Moulder, MS - Principal and Vice President of Portfolio Management. Meghan has a strong background in portfolio management and has been instrumental in guiding portfolio companies.
Chris Moulder, MS, MBA - Principal and Vice President of Operations. Chris focuses on operational efficiency and has a solid track record in managing biotech operations.
Submit your pitch through their website's contact form for consideration.
What are Tellus BioVentures' investment criteria?
Tellus BioVentures focuses on early-stage biotech ventures, primarily at the Seed stage, and participates in Series A investments. They look for companies that are developing innovative therapeutics for unmet medical needs.
How can founders apply or pitch to Tellus BioVentures?
Founders can reach out through the Tellus BioVentures website to inquire about pitching opportunities. A detailed pitch deck outlining the business model, market potential, and team background is recommended.
What makes Tellus BioVentures different from other investors?
Tellus BioVentures often acts as the lead or sole investor in its ventures, providing not only capital but also management support and development expertise to help portfolio companies achieve critical milestones.
What is the geographic scope of Tellus BioVentures' investments?
The firm primarily focuses on investments within the United States, where they can leverage their extensive network and resources to support early-stage biotech companies.
What is the typical check size for investments?
While specific check sizes are not disclosed, Tellus BioVentures typically invests at the Seed stage and participates in Series A rounds, often taking a leading role in funding.
What kind of post-investment involvement does Tellus BioVentures have?
Tellus BioVentures provides ongoing management support and development expertise to its portfolio companies, helping them navigate challenges and achieve their milestones.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.